MARC Record from Scriblio

LEADER: 01999cam 22003738a 4500
001 2005019344
003 DLC
005 20050919074923.0
008 050707s2006 mdu b 001 0 eng
010 $a 2005019344
020 $a0801882826 (hard cover : alk. paper)
035 $a(DNLM)101252005
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC553.C64$bE44 2006
060 10 $aWP 522$bE27 2006
082 00 $a616.8/0461$222
245 04 $aThe effects of estrogen on brain function /$cedited by Natalie L. Rasgon.
260 $aBaltimore :$bJohns Hopkins University Press,$c2006.
263 $a0606
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 0 $aPreclinical data relating to estrogen's effects on cognitive performance / Robert B. Gibbs -- The short-lived effects of hormone therapy on cognitive function / Eva Hogervorst -- Clinical data on estrogen's effects in the central nervous system: data from structural and functional brain imaging / Daniel H.S. Silverman, Cheri L. Geist, and Natalie L. Rasgon -- Clinical data on estrogen's effects in the central nervous system: estrogen and mood / Natalie L. Rasgon, Laurel N. Zappert, and Katherine E. Williams -- Preclinical efforts to develop effective neuroSERMS for the brain / Roberta Diaz Brinton and Liqin Zhao -- Basic and clinical data on the effects of SERMS on cognition / Kristine Yaffe, Pauline M. Maki, and Peter J. Schmidt.
650 0 $aCognition disorders$xEndocrine aspects.
650 0 $aEstrogen$xTherapeutic use$xComplications.
650 0 $aBrain$xEffect of drugs on.
650 0 $aMenopause$xHormone therapy$xComplications.
650 12 $aEstrogen Replacement Therapy.
650 12 $aEstrogens$xpharmacology.
650 22 $aCentral Nervous System$xdrug effects.
650 22 $aCognition$xdrug effects.
650 22 $aRisk Assessment.
700 1 $aRasgon, Natalie L.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0515/2005019344.html